Biogen (BIIB) Other Operating Expenses (2009 - 2026)

Biogen (BIIB) has reported Other Operating Expenses for 18 consecutive years, with -$19.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Operating Expenses rose 71.2% year-over-year to -$19.7 million; the TTM figure through Mar 2026 stood at -$53.8 million (down 2141.67% YoY), while the FY2024 annual figure was -$27.7 million, changed N/A from the prior year.
• Other Operating Expenses came in at -$19.7 million for Q1 2026 at Biogen, up from -$34.1 million in the prior quarter.
• The five-year high for Other Operating Expenses was $428.6 million in Q2 2022, with the low at -$300.0 million in Q3 2023.
• Average Other Operating Expenses over 5 years is $5.8 million, with a median of -$17.2 million recorded in 2024.
• Across the five-year window, Other Operating Expenses surged 344.61% in 2022 and tumbled 1077.46% in 2023, its largest moves.
• Year by year, Other Operating Expenses stood at -$12.2 million in 2022, then slumped by 2359.02% to -$300.0 million in 2023, then jumped by 155.33% to $166.0 million in 2024, then slumped by 120.54% to -$34.1 million in 2025, then jumped by 42.23% to -$19.7 million in 2026.
• According to Business Quant data, Other Operating Expenses over the past three periods registered -$19.7 million, -$34.1 million, and -$68.4 million for Q1 2026, Q3 2025, and Q1 2025 respectively.